Number of items: 4.
2020
Marshall, Andrea, Levine, Mark, Hill, Catherine, Hale, Danielle, Thirlwall, Jenny, Wilkie, Veronica, French, Karen, Kakkar, Ajay K., Lokare, Anand, Maraveyas, Anthony, Chapman, Oliver, Arif, Azra, Petrou, Stavros, Maredza, Mandy, Hobbs, FD Richard, Dunn, Janet A. and Young, Annie M.
(2020)
Treatment of cancer‐associated venous thromboembolism : 12‐month outcomes of the placebo versus rivaroxaban randomisation of the SELECT‐D Trial. (SELECT‐D: 12m).
Journal of Thrombosis and Haemostasis, 18
(4).
pp. 905-915.
doi:10.1111/jth.14752
2018
SELECT-D Collaborative Group (Including: Young, Annie M., Marshall, Andrea, Thirlwall, Jenny, Chapman, Oliver, Lokare, Anand, Hill, Catherine, Hale, Danielle, Dunn, Janet A., Lyman, Gary H., Hutchinson, Charles, MacCallum, Peter, Kakkar, Ajay, Hobbs, F. D. Richard, Petrou, Stavros, Dale, Jeremy, Poole, Christopher J., Maraveyas, Anthony and Levine, Mark).
(2018)
Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism : results of a randomized trial (SELECT-D).
Journal of Clinical Oncology, 36
(20).
pp. 2017-2023.
doi:10.1200/JCO.2018.78.8034
Young, Annie M., Marshall, A. (Andrea), Thirlwall, Jenny, Chapman, O., Lokare, A., Hills, Claire E., Hale, D., Dunn, Janet A., Kakkar, A., Levine, M. and Select-d Collaborative, Group
(2018)
Anticoagulation therapy in SELECTeD cancer patients at risk of recurrence of venous thromboembolism : results of the 'select-d' Pilot Trial.
Thrombosis Research, 164
(Supplement 1).
S194.
doi:10.1016/j.thromres.2018.02.036
2016
Young, Annie M., Phillips, Jennifer, Hancocks, N. Helen, Hill, Catherine, Joshi, Neya, Marshall, A. (Andrea), Grumett, Joanne, Dunn, Janet A., Lokare, A. and Chapman, O.
(2016)
OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
Thrombosis Research, 140
.
S172-S173.
doi:10.1016/S0049-3848(16)30128-1
This list was generated on Wed May 18 07:41:34 2022 BST.